Searched for
SUN PHARMA MD DILIP SHANGHVI
Missed Sun Pharma rally? Ajit Mishra say current dip offers fresh entry opportunity18 May, 2026, 07.00 AM IST- Sun Pharma looks to divest more assets from Ranbaxy stable12 Feb, 2016, 10.27 PM IST
- Sun Pharma may discontinue some non-strategic businesses02 Nov, 2015, 01.27 PM IST
- Dilip Shanghvi addresses investors' concerns on Sun Pharma04 Dec, 2018, 08.28 AM IST
- Sun Pharma posts loss of Rs 2,277 cr in Q4 due to one-time exceptional loss of Rs 3,936 cr30 May, 2022, 04.32 PM IST
- Sun Pharma promoters may hike stake: Sources20 Apr, 2015, 11.22 AM IST
- Dilip Shanghvi overtakes Mukesh Ambani as richest Indian05 Mar, 2015, 09.21 AM IST
- Sun Pharma bids to acquire InSite Vision Inc15 Sep, 2015, 09.24 AM IST
- Merger with Ranbaxy an important milestone: Sun Pharma25 Mar, 2015, 01.21 PM IST
- Regaining trust of regulators our priority: Dilip Shanghvi26 Mar, 2015, 09.09 AM IST
- Dilip Shanghvi to buy into ABG Shipyard?01 Apr, 2015, 07.35 PM IST
- Dilip Shanghvi eyes real estate sector21 Apr, 2015, 10.03 PM IST
- Investors punish Sun Pharma over profit warning21 Jul, 2015, 10.09 PM IST
- Stocks in focus: CG Consumer, Sun Pharma, Dilip Buildcon and more23 Feb, 2022, 08.23 AM IST
- Sun Pharma Q2 Results: Net profit jumps 8% YoY to Rs 2,260 cr; revenue up 14%01 Nov, 2022, 03.18 PM IST
- Ranbaxy acquisition to hit FY16 profit: Sun Pharma20 Jul, 2015, 09.07 PM IST
- Sun Pharma Q1 Results: PAT dips 2% YoY to Rs 2,023 cr on one-time expense03 Aug, 2023, 07.31 PM IST
- Sun Pharma Q2 Results: PAT beats estimates, rises 6% YoY to Rs 2,385 cr; revenue up 11%01 Nov, 2023, 06.21 PM IST
- Sun Pharma Q4 Results: India's largest drugmaker reports net profit of Rs 1,985 crore27 May, 2023, 03.43 PM IST
- Stock Radar: Buy Sun Pharma for a target of Rs 918-935, recommends Ruchit Jain21 Sep, 2022, 12.15 PM IST
Load More
